Skip to main content
David Gorelick, MD, Psychiatry, Baltimore, MD

David A. Gorelick MD

Addiction


Clinical Professor of Psychiatry, University of Maryland School of Medicine Editor-in-Chief, Journal of Cannabis Research

Join to View Full Profile
  • PO Box 21247MPRC--Tawes BldgBaltimore, MD 21228

  • Phone+1 410-402-6806

Dr. Gorelick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • David Gorelick, MD is a psychiatrist based in Baltimore, MD with a subspecialty in addiction. His medical training was completed at the Albert Einstein College of Medicine and residency at the UCLA David Geffen School of Medicine/UCLA Medical Center. He currently serves as a clinical professor of psychiatry at the University of Maryland School of Medicine, editor-in-chief of the Journal of Cannabis Research, and a member of the Maryland Cannabis Public Health Advisory Council. Dr. Gorelick has published more than 215 papers in peer-reviewed medical journals and 65 book chapters and has designed and conducted numerous phase I and II clinical trials related to addiction and its treatment. His work focuses on treatment of substance use disorders and their comorbidity with other psychiatric disorders, such as schizophrenia. A current interest is the public health implications of cannabis legalization

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1977 - 1980
  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1976 - 1977
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - 2027
  • MD State Medical License
    MD State Medical License 1989 - 2026
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Legalization of Marijuana Could Lead to Public Health Concerns, Study Suggests
    Legalization of Marijuana Could Lead to Public Health Concerns, Study SuggestsJanuary 1st, 2020
  • Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
    Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid DependenceJuly 27th, 2006
  • Marijuana Use Highly Linked to Addiction, Psychosis: NEJM
    Marijuana Use Highly Linked to Addiction, Psychosis: NEJMJanuary 5th, 2024

Grant Support

  • Identification Of Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse2009–2010
  • Development Of New Pharmacologic And Biologic Treatments For Drug DependenceNational Institute On Drug Abuse2009–2010
  • Development Of New Pharmacologic And Biologic Treatments For Drug DependenceNational Institute On Drug Abuse2007–2008
  • Identification Of Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse1993–2008
  • Development Of New Pharmacologic And Biologic TreatmentsNational Institute On Drug Abuse2006

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: